Therapy of chronic mucocutaneous candidiasis.
Clinical observations made on a group of six children and three adults indicate that ketoconazole is a safe and effective fungistatic agent that is useful for both initial and long-term maintenance therapy of mucocutaneous lesions due to infection by sensitive strains of Candida in patients with chronic mucocutaneous candidiasis.
D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy*; D002178:Candidiasis, Chronic Mucocutaneous / Q000188:drug therapy* / Q000276:immunology; D002648:Child; D004334:Drug Administration Schedule; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D007654:Ketoconazole; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*
D000935:Antifungal Agents; D007093:Imidazoles; D010879:Piperazines; D007654:Ketoconazole